Open Label, Sequential Dosing , Single Ascending Dose and Multiple Dose Safety Tolerability and Pharmacokinetic Study
Clinical trial NCT06074757 · COMPLETED
Trial details
- NCT number
- NCT06074757
- Sponsor
- Kashiv BioSciences, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2023-09-10
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.